NCT01526434View on ClinicalTrials.gov

Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Rheumatoid Arthritis
Trial Locations (15)

Unknown

11, A Coruña

15, Barcelona

20, Barcelona

4, Barcelona

7, Barcelona

21, Girona

9, Granada

12, León

17, Lleida

18, Lleida

6, Salamanca

10, Seville

14, Tarragona

16, Tarragona

5, Vigo

All Listed Sponsors
collaborator

ReSearch Pharmaceutical Services, Inc.

INDUSTRY

lead

UCB Pharma SA

INDUSTRY

NCT01526434 - Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol | Biotech Hunter | Biotech Hunter